Foundational education for new patients
Long-form, conversational guides that explain GLP-1 therapy from first principles for newcomers and curious researchers alike.
Last reviewed
Topics in this cluster
- How GLP-1 works
- Eligibility
- Starting therapy
- Talking to your doctor
- Stopping safely
Where to start
If you've never used a GLP-1 before, start with the mechanism explainer and the eligibility guide. Together they cover the two questions almost every newcomer asks first: how does this actually work, and am I a candidate. The NIH/NIDDK overview of prescription weight-management medications is a useful neutral starting point, and the cardiovascular benefit signal seen in the SELECT trial is the strongest long-term safety dataset we have for semaglutide outside of diabetes.
Frequently asked questions
Are GLP-1 medications safe for long-term use?+
Current clinical guidelines treat obesity and type 2 diabetes as chronic conditions, meaning GLP-1 therapy is typically continued long-term. Long-term safety data — out to 4+ years — has been broadly reassuring, with cardiovascular benefit signals in trials like SELECT.
How fast will I see results on a GLP-1?+
Most patients see appetite changes within the first 1–2 weeks and measurable weight loss within 4–6 weeks. The full effect of any given dose typically takes 12–16 weeks to manifest.
Knowledge graph · related nodes
How this page connects to the rest of the GLP-1 knowledge base. Each link spans a different cluster — follow the one that maps to your next question.